MOYES JAY M
SEC CIK 1191062 · EDGAR
BoughtSold
Most active insiders at PBYI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AUERBACH ALAN H | Pres, CEO, Dir, 10% | — | $568.9K |
| 2 | Cesano Alessandra | Dir | — | $567.0K |
| 3 | Senderowicz Adrian | Dir | — | $194.3K |
| 4 | MOYES JAY M | Dir | — | $158.8K |
| 5 | NOUGUES MAXIMO F | CFO | — | $141.7K |
| 6 | WILSON TROY EDWARD | Dir | — | $123.2K |
| 7 | HUNT DOUGLAS M | See Remarks | — | $122.6K |
| 8 | MILLER MICHAEL PATRICK | Dir | — | $97.2K |
| 9 | Dorval Allison | Dir | — | $83.6K |
| 10 | Stuglik Brian M | Dir | — | $58.3K |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-15 20:10 | 2026-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | A - Grant | $0.00 | +27.0K | 80.3K | +51% | $0 |
| T | 2026-06-15 20:10 | 2026-06-12 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | S - Sale | $7.22 | -22.0K | 58.3K | -27% | -$158.8K |
| 2026-02-25 | 2026-02-23 | SINT | Sintx Technologies, Inc. | MOYES JAY M | Dir | P - Purchase | $2.91 | +1,000 | 4,000 | +33% | +$2,910 | |
| 2025-08-27 | 2025-08-26 | SINT | Sintx Technologies, Inc. | MOYES JAY M | Dir | P - Purchase | $3.59 | +3,000 | 3,000 | New | +$10.8K | |
| 2025-06-17 | 2025-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | S - Sale | $3.40 | -22.0K | 53.3K | -29% | -$74.8K | |
| 2025-06-13 | 2025-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | A - Grant | $0.00 | +27.0K | 75.3K | +56% | $0 | |
| 2024-06-21 | 2024-06-18 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | A - Grant | $0.00 | +27.0K | 48.3K | +127% | $0 | |
| 2024-06-17 | 2024-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | S - Sale | $3.34 | -22.0K | 21.3K | -51% | -$73.5K | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | S - Sale | $3.45 | -22.0K | 16.3K | -57% | -$75.9K | |
| 2023-06-15 | 2023-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | A - Grant | $0.00 | +27.0K | 43.3K | +165% | $0 | |
| D | 2023-03-07 | 2023-03-06 | SERA | SERA PROGNOSTICS, INC. | MOYES JAY M | CFO | A - Grant | $0.00 | +32.8K | 35.6K | +1,159% | $0 |
| 2022-06-21 | 2022-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | S - Sale | $2.64 | -22.9K | 38.3K | -37% | -$60.3K | |
| 2022-06-17 | 2022-06-14 | PBYI | PUMA BIOTECHNOLOGY, INC. | MOYES JAY M | Dir | A - Grant | $0.00 | +27.0K | 61.2K | +79% | $0 | |
| DM | 2021-07-21 | 2021-07-19 | SERA | SERA PROGNOSTICS, INC. | MOYES JAY M | CFO | C - Cnv Deriv | — | +2,830 | 2,830 | New | — |
Purchase Sale Sale after option exercise All abbreviations